Benefit of Aspirin Could Depend on Lipoprotein(a) Levels, Study Finds
An analysis of NHANES found aspirin's benefits in primary prevention may hinge on lipoprotein(a) (Lp(a)) levels, halving ASCVD mortality risk with Lp(a) ≥50 mg/dL.
Stay updated with breaking news from Services Task Force Recommendation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An analysis of NHANES found aspirin's benefits in primary prevention may hinge on lipoprotein(a) (Lp(a)) levels, halving ASCVD mortality risk with Lp(a) ≥50 mg/dL.
A secondary analysis of ASPREE is bringing the role of aspirin in primary prevention settings further into question, suggesting daily use of low-dose aspirin was associated with a 38% increase in intracranial bleeding in older adults.
Ideally, screening tests for hearing loss should be conducted before the infant is 1 month of age.
A new study reviewed evidence from trials and studies to assess the risks and benefits of using statins to prevent or reduce morbidities or mortalities related to cardiovascular disease (CVD).
Today's Dietitian magazine, the leading news source for dietitians and nutritionists, covering topics such as diabetes management, long-term care, new products and technologies, career strategies, nutrition research updates, supplements, culinary arts, food allergies, fitness, sports medicine, and much more.